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ABSTRACT
The sympathetic nervous system is important in maintaining cardiovascular homeostasis.
Elevated cardiovascular-related sympathetic activity can lead to neurogenic hypertension
and a host of other serious cardiac-related abnormalities. The paraventricular nucleus
(PVN) of the hypothalamus plays an important role in sympathetic cardiovascular
regulation. Neurons from the PVN project to the rostral ventrolateral medulla (RVLM),
which is the main brain stem sympathetic cardiovascular control center. While RVLMprojecting PVN neurons have been well characterized, the topographical organization
within the PVN subnuclei is still not fully known. This neuroanatomical study aimed to
map the topographical distribution of RVLM-projecting PVN neurons. Four different
carboxylate FluoSphereTM retrograde tracers (blue, 365/415; green, 505/515; red,
565/580; and far-red, 660/680) were injected at different rostro-caudal coordinates within
the RVLM. The vast majority of RVLM-projecting PVN neurons were ipsilateral and
located in the medial parvocellular subnucleus. Whereas most neurons were ipsilateral,
there is a small fraction of neurons that crossed the midline. RVLM-projecting neurons
were also identified within the dorsal, ventral, and posterior parvocellular subnuclei of
the PVN with no labeling found in the anterior parvocellular or magnocellular subnuclei.
Additionally, we observed different efficiencies of the retrograde tracers with blue
(365/415) being the least efficient and red (565/580) being the best. These
neuroanatomical data will serve as important preliminary data for future research
investigating the functional and histochemical properties of these PVN neurons.
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CHAPTER ONE
INTRODUCTION
Hypertension is a primary contributor to heart failure which is the leading cause
of death worldwide [1,2]. Activation of the sympathetic nervous system increases heart
rate and blood pressure. When the sympathetic nervous system becomes chronically
overactive it can lead to neurogenic hypertension [1,2]. A better understanding of the
neural pathways involved is important to the etiology and treatment of neurogenic
hypertension.
The hypothalamic paraventricular nucleus (PVN) has been shown to be an
important autonomic site mediating the sympathetic functions in cardiovascular
regulation. Previous studies have shown that activation of the PVN results in increased
blood pressure and rate of respiration [12]. The rostral ventrolateral medulla (RVLM) is
the primary sympathetic cardiovascular control center that regulates blood pressure.
Excitation of the RVLM increases heart rate and blood pressure [21,22]. Previous studies
have shown that the PVN projects to the RVLM [12,17,18]. The aim of our study was to
identify which subnuclei of the PVN contain these RVLM-projecting neurons. To do this,
we bilaterally microinjected four different retrograde tracers (FluoSpheresTM) into the
RVLM. We identified which PVN subnuclei contained labeled RVLM-projecting
neurons using fluorescent microscopy.
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CHAPTER TWO
REVIEW OF LITERATURE

Autonomic Regulation of the Cardiovascular System
The parasympathetic and sympathetic nervous systems both act to maintain
cardiovascular homeostasis. The parasympathetic nervous system is most active when
there are no stress-inducing stimuli detected and the body is in a relaxed state. The
sympathetic nervous system is activated in the event of a perceived emergency to prepare
the body for energy expenditure [1]. The activity of the sympathetic nervous system is also
vital in maintaining cardiovascular function on a moment-to-moment basis [2]. The degree
to which the parasympathetic or sympathetic nervous system gets activated is dependent
upon the type of stimuli encountered in both the external and internal environments [1].
Sympathetic activation increases cardiac output, systemic blood pressure, and the
rate of respiration. Sympathoexcitation of the sinoatrial node, myocardium, and
atrioventricular node causes an increase in heart rate, stroke volume, and atrioventricular
conduction velocity which all contribute to the elevated cardiac output [1,4]. Sympathetic
activation of the blood vessels causes vasoconstriction which increases blood pressure [5].
Activation of the sympathetic nervous system also causes bronchodilation which facilitates
the increased rate of respiration [6,7].
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Sympathetic Mechanisms of Cardiovascular Regulation
Cardiovascular sympathetic regulatory mechanisms rely on the relationship
between receptors, control centers in the central nervous system, and effector organs. There
are two primary sources of afferent input relevant to sympathetic cardiovascular regulation:
chemoreceptors and baroreceptors [8]. Chemoreceptors are sensory receptors that detect
changes in oxygen, carbon dioxide, and pH levels in the body. Peripheral chemoreceptors
are sensory receptors of the peripheral nervous system found in the aortic bodies and
carotid bodies. Central chemoreceptors are sensory neurons of the central nervous system
found in various regions in the brain and brainstem, primarily on the surface of the
ventrolateral medulla. Arterial baroreceptors in the aortic arch and carotid sinuses are
mechanoreceptor sensory neurons that detect a change in arterial blood pressure [1].
The cardiorespiratory chemoreflex occurs in response to hypoxemia (low oxygen
levels in the blood) and hypercapnia (excess levels of carbon dioxide in the blood). When
activated by a change in the level of oxygen, carbon dioxide, or pH, peripheral
chemoreceptors in the carotid and aortic bodies send action potentials through their afferent
fibers in cranial nerves IX and X respectively [1]. These afferent fibers relay their sensory
information to secondary interneurons in the nucleus tractus solitarius (NTS) in the dorsal
medulla which manages various visceral afferent sensory inputs. The NTS then relays this
information to respiratory control centers and both directly and indirectly to the rostral
ventrolateral medulla (RVLM). From here, efferent signals from the RVLM travel to the
intermediolateral column (IML) of the spinal cord to synapse with the sympathetic
preganglionic motor neurons [9]. The NTS also sends axonal projections to the
8

paraventricular nucleus in the hypothalamus (PVN). The PVN sends projections directly
to the IML as well as the RVLM and can therefore affect sympathetic activity directly
through the spinal cord or indirectly through its projections to the RVLM. The PVN also
sends projections to the pre-Botzinger complex and phrenic motor neurons which are both
important in controlling ventilation [12]. Central chemoreceptors are primarily activated in
response to increased levels of carbon dioxide (hypercapnia) and decreased pH in the
interstitial fluid and cerebrospinal fluid in the brain. These receptors send their sensory
information to the respiratory control centers in the brainstem and to the sympathetic
regions, primarily the RVLM [10].
The arterial baroreflex is the primary mechanism of control by which the autonomic
nervous system regulates short-term blood pressure. Primary afferent fibers of the arterial
baroreceptors in the carotid sinuses and aortic arch continuously send impulses through the
glossopharyngeal nerve (CN IX) and the vagus nerve (CN X) respectively [9]. These
impulses are received by secondary interneurons in the NTS and then relayed directly to
the nucleus ambiguous (NA) in the medulla, which contains parasympathetic cardiac vagal
motor neurons. Here, in the event of high blood pressure, the parasympathetic nerve
activity is increased to lower heart rate. The NTS also projects the impulses to interneurons
in the caudal ventrolateral medulla (CVLM) which sends inhibitory projections to the
sympathetic premotor neurons in the RVLM [9]. Increased baroreceptor activity inhibits
the sympathetic outflow to the heart and vasculature which lowers blood pressure. When
baroreceptor activity is attenuated, however, parasympathetic vagal activity is decreased
while sympathetic activity in the RVLM is increased to raise arterial blood pressure [9].
9

Sympathetic activation in response to conditions such as hypoxemia, hypercapnia,
and hypotension relies primarily on the same basic mechanisms of action. Sympathetic
activation increases ventilation, cardiac output, and blood pressure [10]. Sympathetic
stimulation is coupled with augmented phrenic nerve activity resulting in increased
ventilation [7]. The coupling of increased sympathetic nerve activity (SNA) with increased
phrenic nerve activity could be the result of PVN projections to the phrenic motor nucleus
in the spinal cord [12]. Activation of beta-2 adrenergic receptors found in human airways
causes bronchodilation which aids in increasing ventilation and is caused by the activation
of beta-2 adrenergic receptors found in human airways. Beta-2 adrenergic receptors are
activated by circulating catecholamines (primarily epinephrine) released by the adrenal
medulla upon sympathetic stimulation [11].
Sympathoexcitation augments cardiac output by stimulating the release of
norepinephrine from postganglionic sympathetic nerves innervating the SA node, AV
node, and the myocardium. Norepinephrine released by these postganglionic sympathetic
nerve fibers activates the alpha-1 and beta-1 adrenergic receptors found within the heart.
Circulating epinephrine also primarily activates beta-2 adrenergic receptors found in the
heart [1]. The release of norepinephrine by postganglionic sympathetic nerves innervating
the vascular smooth muscle causes vasoconstriction, thus increasing peripheral resistance.
The norepinephrine released by these sympathetic fibers acts on the alpha-1 adrenergic
receptors in blood vessels and also the alpha-2 adrenergic receptors [5]. Blood pressure can
also be increased by stimulation of the posterior pituitary via projections from the PVN,
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which causes the release of vasopressin into the bloodstream by the posterior pituitary.
This release of vasopressin increases water retention and causes vasoconstriction [12].

The Paraventricular Nucleus
The PVN is an important site in mediating the autonomic and neuroendocrine
regulation of several physiological functions. The PVN is specifically involved in
sympathetic cardiovascular regulation [12]. The PVN is a bilateral structure in the
hypothalamus that borders the third ventricle. The PVN stretches rostrocaudal alongside
the third ventricle and is the dorsal most component of the thalamic-intralaminar nuclear
complex in the rat [13]. Previous studies categorized the neurons within the PVN into two
main groups: the magnocellular neurons and parvocellular neurons [12,14]. Magnocellular
PVN neurons primarily project to the posterior pituitary gland to release vasopressin and
oxytocin. Parvocellular PVN neurons are more diverse in function. The medial portion of
the PVN parvocellular division projecting to the median eminence has a neuroendocrine
function centered around the secretion of thyrotropin-releasing hormone and corticotropinreleasing hormone into the hypophyseal portal system [14]. The medial portion alongside
the dorsal, ventral, and posterior portions of the PVN parvocellular division all have a
major autonomic role with projections to NTS, RVLM, sympathetic preganglionic neurons
in the spinal cord, among other areas of the CNS [12].
The PVN plays a significant role in mediating the sympathetic response to hypoxia.
Afferent inputs from chemoreceptors reach the NTS and are relayed to the PVN and other
CNS sites. Studies have shown that the PVN contributes significantly to the sympathetic
11

response to hypoxia primarily by increasing ventilation, heart rate, and blood pressure
[12,13,15]. The PVN does not appear to play a significant role in mediating the response
to hypercapnia [12,16]. Increased blood volume has also been shown to inhibit PVN
activity. Decreased blood volume (hypovolemia) augments general sympathetic activity,
however, the PVN only plays a minor role in this response to hypovolemia [17].
The PVN plays an important role in maintaining adequate blood pressure in the
event of sustained dehydration. Studies suggest that this increased PVN activity is a result
of an increase in osmolarity during dehydration and not the decreased blood volume
component of dehydration [17]. The PVN can affect blood pressure via the neuroendocrine
route by stimulating the release of vasopressin by the posterior pituitary gland into the
bloodstream which causes vasoconstriction and fluid retention [12,14]. It has also been
shown that the PVN mediates the control of blood pressure its connections with the RVLM.
The PVN has been shown to have some involvement with the baroreflex decreases in SNA
by specifically inhibiting lumbar SNA [17].

Afferent Inputs to the PVN
The PVN receives afferent inputs from the brainstem, other hypothalamic nuclei,
and various other structures in the CNS. From the medulla, the NTS directly provides the
PVN with afferent input integrated from chemoreceptors and baroreceptors. A1 and C1
cell groups from the ventrolateral medulla along with the A2 and C2 cell groups of the
dorsal vagal complex also send projections to the PVN. Furthermore, the A5 cell group,
A6 cell group (locus coeruleus), and the parabrachial nucleus of the pons all send
12

projections to the PVN [12, 17-18]. Inputs to the PVN from other hypothalamic subnuclei
come from the dorsomedial nucleus, suprachiasmatic nucleus, arcuate nucleus, median
preoptic nucleus, and the perifornical area. The inputs from these areas to the PVN are
related to emotional stress, circadian rhythms, leptin and insulin levels, osmoregulation,
and thermoregulation [18]. Some notable areas outside of the brainstem and hypothalamus
that send projections to the PVN include the subfornical organ, organum vasculosum
lamina terminalis, and the bed nucleus of the stria terminalis. These areas relay information
relating to angiotensin II levels, blood osmolarity, and emotional stress. The PVN also
receives direct projections from the dorsal horn of the spinal cord via the
spinohypothalamic tract which primarily carries information from nociceptors regarding
painful stimuli [12,17,18].

Efferent Projections from the PVN
The PVN sends efferent projections to key neuroendocrine CNS control sites,
various autonomic regulatory sites, and directly to the spinal cord. The PVN’s efferent
projections to brainstem autonomic regulatory sites include projections to the midbrain,
pons, and medulla. The PVN efferent projections to the midbrain include projections to the
central gray matter/periaqueductal gray and to the Edinger-Westphal nucleus [12,17,18].
In the pons, the PVN projects to the pedunculopontine tegmental nucleus, locus coeruleus,
and parabrachial nucleus. In the medulla, the PVN projects to the NTS, dorsal motor
nucleus of the vagus, caudal pressor area, nucleus ambiguous, pre-B complex, and the
RVLM. Finally, the spinally projecting neurons of the PVN project to the IML primarily
13

to the T1-T3 and T9-L3 spinal levels. A portion of these spinally projecting PVN neurons
send collaterals to the RVLM. Studies have also suggested that the PVN sends projections
to the phrenic motor neurons in the cervical spinal levels [12,17,18].

The Rostral Ventrolateral Medulla
The RVLM is a major site in the brainstem responsible for the sympathetic
regulation of cardiac output and blood pressure. The RVLM is a dense column of cells
running longitudinally near the ventral surface of the medulla. It is located ventral to the
retrofacial nucleus in the medulla. The RVLM is bordered rostrally by the facial motor
nucleus, medially by the gigantocellular reticular formation, laterally by the trigeminal
nucleus, and caudally by the lateral reticular nucleus [19,20]. C1 adrenergic neurons are
found throughout the RVLM and play a significant role in cardiovascular function. These
RVLM C1 neurons can be subcategorized into three groups based on where they send
projections to. Various non-C1 neurons also make up the RVLM which may also aid in its
cardiovascular functions [19].
The RVLM plays an essential role in maintaining blood pressure through its spinal
projections to sympathetic preganglionic neurons. Through its spinal projections, the
RVLM can in turn affect vasomotor tone, cardiac output, and adrenomedullary
catecholamine release [21,22]. Studies have shown that excitation of the presympathetic
RVLM neurons increased cardiovascular-related sympathetic nerve activity [21,22]. The
increased sympathetic activity to vascular smooth muscle and the heart increases vascular
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resistance/vasoconstriction and heart rate. Inhibition of the RVLM by lesions or by
microinjections of inhibitory neurotransmitters decreases blood pressure [21].
The RVLM is notably involved in the arterial baroreflex in which sympathetic
activity is maintained on a moment-to-moment basis. Increases in blood pressure stimulate
arterial baroreceptors and increase the firing frequency to the NTS. The NTS projects to
the GABAergic-CVLM neurons which decreases the tonic firing of the RVLM, thus
decreasing sympathetic outflow to the heart and blood vessels. A decrease in blood
pressure reduces the firing frequency of the baroreceptor afferents and increases the RVLM
sympathetic outflow to the heart and blood vessels to restore adequate blood pressure [9,
21-23].
The RVLM is also an important component of the chemoreflex pathway.
Chemoreceptor input reaches the RVLM through the same essential pathway that the
baroreceptor input takes, only the NTS projections regarding chemoreceptor inputs bypass
the CVLM to project directly to the RVLM. The difference is that, unlike increased
baroreceptor input, augmented chemoreceptor input (triggered by hypoxia or hypercapnia)
results in excitation of the RVLM, which in turn triggers an increase in heart rate and blood
pressure. Studies have shown that inhibition or destruction of the RVLM results in a loss
of these cardiovascular reflexes, indicating that the RVLM is a vital part of these reflex
pathways [22-23].
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Afferent Inputs to the RVLM
The RVLM receives various afferent inputs from brainstem regions, higher brain
regions, and the spinal cord as demonstrated by several anatomical studies [9,22,24]. In the
medulla, afferent inputs to the RVLM arise from the NTS, CVLM, medullary raphe nuclei,
Botzinger complex, pre-Botzinger complex, lateral tegmental field, nucleus propositus
(also found in the pons), medullary trigeminal nucleus, and the medullary vestibular
nucleus [9,22,24]. From the pons, the RVLM receives afferent input from the locus
subcoeruleus nucleus, Kolliker-Fuse/subparabrachial nucleus, and the medial and lateral
parabrachial nuclei. Afferent inputs to the RVLM also arise from the periaqueductal
gray/central gray matter and the A5 cell group located in the midbrain of the brainstem.
The higher brain regions that send afferent input to the RVLM primarily include the
hypothalamus and the amygdala. From the hypothalamus, the RVLM receives afferent
input from the PVN, the DMH, and the lateral hypothalamic area. From the amygdala, the
RVLM receives afferent input from the central amygdaloid nucleus [9,22,24]. Spinobulbar
neurons also directly innervate the RVLM. The information carried to the RVLM from the
spinal cord primarily arises from skeletal muscle receptors and skin nociceptors [9].

Efferent Projections from the RVLM
The RVLM sends efferent projections primarily to areas within the brainstem,
hypothalamus, and spinal cord. Within the brainstem, the RVLM projects to a few key
areas in the medulla, pons, and midbrain. In the medulla, the RVLM sends projections to
the NTS and to the dorsal motor nucleus of the vagus (DMV). The RVLM also sends
16

efferent projections to the area of the dorsolateral pons. The midbrain periaqueductal
gray/central gray matter receives projections from the RVLM. In the hypothalamus, the
RVLM projects to the PVN, the supraoptic nuclei, median preoptic nucleus, and to the
DMH. Spinal projecting neurons from the RVLM synapse with sympathetic preganglionic
neurons in the IML of the thoracolumbar spinal sections [9,19].
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CHAPTER THREE
METHODS

Animals
Three adult male Sprague-Dawley rats (Envigo, Indianapolis, IN) weighing 250300g were used for this study. The procedures and protocols described below are in accord
with the National Institutes of Health guidelines and were approved by the Institutional
Animal Care and Use Committee at East Tennessee State University. Rats were maintained
in our animal facility in standard conditions of light (12-h light/dark cycle) and temperature
(22 °C).
Surgical Preparations
Rats were initially anesthetized in an induction chamber using 4-5% isoflurane in
O2 until an adequate anesthetic state was confirmed by the absence of a withdrawal
response to painful stimuli in the form of a tail pinch. The fur around the skull and neck
was then trimmed and the rats were weighed. Rats were then placed in the supine position
with their heads secured into a stereotaxic apparatus (Kopf Instruments, Tujunga, CA) and
isoflurane anesthesia was reduced to 2% and resumed through the use of a nose cone. Body
temperature was monitored with a rectal thermometer and maintained at 37 °C with a
servo-controlled heating lamp. The dorsal surface of the head and neck was then cleaned
with betadine and alcohol. A 1.5 cm incision was made in the skin over the occipital bone
of the skull. Tissue and membrane were then cleared exposing the occipital bone. An
occipital craniotomy was performed in which a small burr hole was made exposing the
dorsal surface of the cerebellum at the level of the RVLM.
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RVLM Microinjections
Bilateral microinjections of four different FluoSpheresTM into the RVLM was
performed using a Nanoject III (Drummond Scientific, Broomall, PA) affixed to the
stereotaxic apparatus. A small glass microinjection pipette with a tip diameter of 20-30 μm
was used in conjunction with the Nanoject III (Drummond Scientific, Broomall, PA). The
glass pipette was advanced into the region of the RVLM while being monitored with a
surgical microscope. 100 nanoliters of each FluoSphereTM were injected bilaterally into its
assigned rostral-caudal area and the glass pipette was left in place for ~1 minute to ensure
adequate diffusion of the retrograde tracer. In the left RVLM, green FluoSpheresTM
(505/515), blue FluoSpheresTM (365/415), and red FluoSpheresTM (565/580) were injected
(100 nL) in rostral-caudal order. In the right RVLM, only far-red FluoSpheresTM (660/680)
were injected (100 nL). After the injections, the overlying membrane and tissue was
sutured, and the wound was stapled closed [25].
Recovery
Following the surgical procedures, rats were administered the NSAID analgesic –
meloxicam via subcutaneous injection at a dose of 1mg/kg. Rats were then placed back
into cages and monitored for ~30 minutes while they regained consciousness to ensure they
were healthy and recovered. Rats were then returned to the isolation room in the vivarium
and were monitored daily for one week.
Perfusion
It has been shown that 5-7 days is sufficient enough time for the retrograde tracers
to travel to the PVN. A week after receiving microinjections, rats were transcardially
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perfused using paraformaldehyde under isoflurane anesthesia. Rats were initially
anesthetized in an induction chamber with 4-5% isoflurane in O2 and then transitioned to
a nose cone. Adequate depth of anesthesia was again assessed and confirmed by the
absence of withdrawal response following a tail pinch. A thoracotomy was then performed
exposing the heart. The right atrium was cut to allow for drainage of the perfusion fluids
to drain into a biosafety hazard approved receptacle. A metal cannula with 18” of attached
silicone tubing was inserted into the ascending aorta through the left ventricle. Cold
buffered heparin-saline (300 mL, 60 mL/min) was used as the rinse/wash agent for the
perfusion. Cold, fresh, buffered 4% paraformaldehyde (300 mL, 60 mL/min) was then used
as the fixative agent for the perfusion. Following the perfusion, brains and brain stems were
quickly removed and post-fixed in 4% paraformaldehyde for 24 hours. After the postfixation, brains and brain stems were cryoprotected by soaking in a 30% sucrose solution
for 48 hours [26].
Preparing Brain and Brainstem Sections
Cryoprotected brains and brainstems were sectioned on a freezing microtome.
Brain stem sections (40 μm) were cut at the level of the RVLM to verify the microinjection
site. For hypothalamic PVN sections, every other 40 μm section was collected from the
posterior body of the anterior commissure to the posterior hypothalamus [27]. Brain and
brainstem sections were placed into a 24 well tray containing phosphate buffered saline
(PBS). Brain and brainstem sections were then mounted onto glass slides and cover slipped.
Analysis
Slides were dried overnight and then examined with a fluorescence Olympus BH2
microscope (Center Valley, PA) for retrograde tracing/labeling in the PVN. A rat brain
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atlas was used to determine which sections contained the PVN. The PVN was defined in
stereotaxic coordinates as the bilateral structure bordering the third ventricle from bregma
-0.60mm to bregma -2.28mm [27]. We counted neurons labeled with fluorescence within
the area of the PVN for each 40 μm section. A digital camera affixed to the fluorescent
microscope was used to project images to a large monitor to facilitate the counting of
neurons while ensuring none were double counted. Images of selected brain sections were
obtained using an Olympus BX63 automated fluorescence microscope (Center Valley, PA)
equipped with a Hamamatsu C11440 digital camera (Bridgewater, NJ).
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CHAPTER FOUR
RESULTS
Identification of PVN Subnuclei Containing RVLM-Projecting Neurons
To identify neurons within the PVN that send axonal projections to the RVLM,
we injected four different FluoSpheresTM into the RVLM. Green (505/515), blue
(365/415), and red (565/580) FluoSpheresTM were injected rostro-caudally into the left
RVLM and far-red (660/680) FluoSpheresTM were injected into the right RVLM.
Histological analysis showed that only the red and green fluosphere microinjections were
located within the left RVLM (figure 1).
Figure 1

Figure 2

Following the microinjections, we inspected the fluorescent retrograde labeling
within the PVN. Of the seven subnuclei within the PVN, we identified four that contained
retrogradely labeled neurons, these being the ventral parvocellular, dorsal cap
parvocellular, medial parvocellular, and the posterior parvocellular subnuclei. These four
22

subnuclei expressed the best labeling at three levels which are shown by the
representative Nissl stain images (figure 2). Neurons in these PVN subnuclei exhibited
fluorescent retrograde labeling with only the green (505/515) and red (565/580) tracers.
There was no retrograde labeling visible at any level within the PVN with either the blue
(365/415) or far-red (660/680) tracers. There was also no labeling of any kind in the
remaining three PVN subnuclei which includes the anterior parvocellular, medial
magnocellular, and lateral magnocellular subnuclei.
The mean number of RVLM-projecting PVN neurons identified was 369 (± 37.4).
Of these, 293.3 (± 57.8) were labeled with the red (565/580) fluosphere and 75.7 (± 39.5)
were labeled with the green (505/515) fluosphere. Regarding laterality, 88.4% of labeled
neurons were located in the ipsilateral PVN, while 11.6% of the labeled neurons were
located in the contralateral PVN. The ventral parvocellular (PaV) subnucleus contained a
mean of 15 (± 2.5) RVLM-projecting neurons. Of these, 13.7 (± 3.4) neurons were
labeled red and 1.3 (± 0.9) were labeled green (figure 3). The dorsal cap parvocellular
(PaDC) subnucleus contained a mean of 44.3 (± 15.1) RVLM-projecting neurons. Of
these, 36 (± 14.1) neurons were labeled red and 8.3 (± 5.2) were labeled green (figure 4).
Figure 3: Ventral Parvocellular Subnucleus
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Figure 4: Dorsal Cap Parvocellular Subnucleus

The medial parvocellular (PaMP) subnucleus contained a mean of 223.7 (±28.9) RVLMprojecting neurons. Of these, 169.3 (±21.1) neurons were labeled red and 54.3 (±31.2)
were labeled green (figure 5). The posterior parvocellular (PaPO) subnucleus contained a
mean of 86 (±22.1) RVLM-projecting neurons. Of these, 74.3 (± 26) neurons were
labeled red and 11.7 (± 6) were labeled green (figure 6). In all four of the subnuclei, the
majority of the RVLM-projecting neurons were labeled with the red (565/580)
FluoSpheresTM and were found on the ipsilateral side (figure 7).
Figure 5: Medial Parvocellular Subnucleus
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Figure 6: Posterior Parvocellular Subnucleus

Figure 7: Summary Retrograde Labeling
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CHAPTER FIVE
DISCUSSION

In past anatomical studies, it has been demonstrated that the PVN sends axonal
projections to the RVLM. These RVLM-projecting neurons have been shown to originate
primarily from within the parvocellular division of the PVN. Furthermore, these PVNRVLM projections have also been shown to be predominately ipsilateral [12,28]. The
results from the present study support these findings in that all of the labeled neurons found
were parvocellular and were ipsilateral to the brainstem injection site. Our study further
characterized the distribution of these RVLM-projecting neurons within the seven
subnuclei of the PVN. Using fluorescent retrograde tracing, we identified four specific
subnuclei that contained RVLM-projecting neurons which include the ventral, dorsal cap,
posterior, and medial parvocellular subnuclei. The medial parvocellular subnucleus
contained the majority of these RVLM-projecting neurons.
The sympathetic role of these PVN neurons in cardiovascular regulation has been
investigated by several studies. These studies have shown that these RVLM-projecting
PVN neurons terminate at the neurons within the RVLM that project to the IML of the
spinal cord [17,22,29-32]. These sympathetic RVLM premotor neurons synapse in the IML
with preganglionic neurons involved with cardiovascular regulation. This suggests that the
PVN has an important role in mediating the sympathetic responses produced by the RVLM.
26

The PVN is an autonomic premotor nucleus that has direct projections to the IML as well
as collaterals that branch to the IML-projecting RVLM neurons. As such, the PVN can
directly regulate cardiovascular activity independent of the RVLM [28].
The results from our study also suggest that the different fluorescent retrograde
tracers used (FluoSpheresTM) did not act in an equally efficient manner. All of these
FluoSpheresTM used had carboxylate-modified coupling surfaces but had different colors
of dye used for labeling. The red (565/580) FluoSphereTM was the most robust at labeling
neurons. It accounted for a majority of the labeling and was very easy to visualize under a
fluorescent microscope. The green (505/515) FluoSphereTM was less effective than the red
but more effective than the blue and far-red tracers. The green tracer still exhibited neuronal
labeling but was harder to visualize than the red tracer. The green could have been harder
to see in general, or it could be that it was not taken up as a tracer as well as the red was.
Initially, we thought that this may be caused by the injection site of the green tracer being
more rostral to the red which would suggest that the majority of RVLM-projecting PVN
neurons innervate the medial aspect of the RVLM. However, this is speculative since the
injection sites of the green and red overlapped in several instances. A smaller volume of
injectant could be useful in the future for keeping each tracer isolated to its own area within
the RVLM in order to better differentiate between the effectiveness of each.
The blue (365/415) and the far-red (660/680) FluoSpheresTM did not exhibit any
labeling at any level of the PVN. In the case of the blue tracer, this is likely to be the result
of a problem with the tracer itself. The blue tracer was confirmed to be injected into the
area of the RVLM in our experiments, however, it produced no labeling in the PVN. The
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only differing factor of this tracer is that it was of smaller size (.02μm instead of .04μm)
than the other tracers. A similar type of tracer that was of the same size labeled with
rhodamine had been previously shown to be effective as a neuronal retrograde tracer [33].
This could mean that the problem is with the type of blue dye used that makes it difficult
to visualize. The lack of ability to produce labeling in the PVN with the far-red tracer was
most likely due to the location of the injection site and not a problem with the tracer itself.
Examination of the brainstem injection sites suggests that the far-red tracer injection in the
right brainstem was too medial to enter the area of the RVLM.

Conclusion
Inputs to the PVN and RVLM mediate changes in sympathetic tone that affect heart
rate and blood pressure. Activation of neurons within the PVN that project to the RVLM
can lead to an increase in sympathetic activity resulting in elevated blood pressure. The
specific subnuclei that contain these RVLM-projecting neurons were identified in this
study. The anatomic data provided by this study will serve as important preliminary data
for future studies investigating the functional and histochemical properties of these
neurons.
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APPENDIX A

FIGURE 1
Brain Stem Microinjections Sites

Figure 1: Composite image showing the brain stem injection sites of both the green (top)
and red (bottom) tracers at their respective levels within the brainstem. The green (505/515)
tracer was injected more rostrally into the RVLM. The red (565/580) tracer was injected
more caudally into the RVLM.
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FIGURE 2
Representative Nissl Stain Images of PVN

Figure 2: Representative image for one rat showing the area of the PVN in the sagittal
section with representative Nissl stain images corresponding to the levels of the PVN that
we took actual images of the neuronal labeling. Also shown is the corresponding image
from the brain atlas with the PVN subnuclei highlighted in yellow.
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FIGURE 3
Ventral Parvocellular Subnucleus (PaV) at Bregma -1.72mm

A.
B.

Figure 3: Representative image for one rat showing the PVN emphasizing the ventral
parvocellular subnucleus (PaV) – (left 10x, right 20x merged) showing differential
fluorescence. PaV is outlined in white. Grouped data showing the mean number of green
(A) and red (B) neurons in the ipsilateral and contralateral ventral subnucleus of the PVN.
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FIGURE 4
Dorsal Cap Parvocellular Subnucleus (PaDC) at Bregma -1.92mm

A.
B.

Figure 4: Representative image for one rat showing the PVN emphasizing the dorsal cap
parvocellular subnucleus (PaDC) – (left 10x, right 20x merged) showing differential
fluorescence. PaDC is outlined in white. Grouped data showing the mean number of green
(A) and red (B) neurons in the ipsilateral and contralateral dorsal cap subnucleus of the
PVN.
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FIGURE 5
Medial Parvocellular Subnucleus (PaMP) at Bregma -1.92mm

A.
B.

Figure 5: Representative image for one rat showing the PVN emphasizing the medial
parvocellular subnucleus (PaMP) – (left 10x, right 20x merged) showing differential
fluorescence. PaMP is outlined in white. Grouped data showing the mean number of green
(A) and red (B) neurons in the ipsilateral and contralateral medial subnucleus of the PVN.
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FIGURE 6
Posterior Parvocellular Subnucleus (PaPO) at Bregma -2.04mm

A.
B.

Figure 6: Representative image for one rat showing the PVN emphasizing the posterior
parvocellular subnucleus (PaPO) – (left 10x, right 20x merged) showing differential
fluorescence. PaPO is outlined in white. Grouped data showing the mean number of green
(A) and red (B) neurons in the ipsilateral and contralateral posterior subnucleus of the PVN.
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FIGURE 7
Summary Retrograde Labeling

Figure 7: Summary data of the combined red and green retrograde tracing in the PVN
showing the distribution of RVLM-projecting neurons within the different subnuclei of the
PVN, shown in yellow. PaMP (Medial PVN), PaPO (Posterior PVN), PaDC (Dorsal Cap),
PaV (Ventral PVN).
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